< Back to latest news & events

Event

RAPS European Digital Technologies and Software conference

October 2025

HGF is proud to be attending the RAPS European Digital Technologies and Software conference in The Netherlands on 30th-31st October.

HGF Partner and Patent Attorney Janine Swarbrick and Patent Director Roxna Kapadia will be speaking on the plenary masterclass Developing a Killer Intellectual Property Strategy for your AI Innovation:

Not to be missed, a masterclass on patent strategy development in the software/AI space from two patent attorneys from HGF, a firm which is highly ranked among Europe’s top patent firms. Artificial intelligence (AI) is playing an increasingly significant role in the rapidly evolving fields of healthcare and medical technology. With this innovation comes a complex legal landscape, particularly in relation to patent protection for AI-focused inventions in the physics/software and life sciences sectors. Guidance on strategy development, pitfalls and detailed requirements will be provided covering both physics/software and life science aspects of innovations in this space.

Learning Objectives

  • Understand how IP rights can be obtained and used to protect AI innovations in healthcare and life sciences
  • Hear case studies where IP strategies have successfully supported business goals in healthcare companies, and where early IP advice would have been beneficial.
  • Explore best practice in-house for identifying, and retaining value from, AI innovations in your business.

Janine will also be speaking on the opening plenary session Regulatory Compliance in the Age of AI:

We all feel that AI is rapidly transforming the regulatory compliance landscape and the trend will only accelerate in the coming years. AI is already impacting compliance and has immense potential to fundamentally change the field as we know it. We all need to do something with this- but what? And how? Let’s hear from our panelists.

Click the button to find out more.

Latest updates

T 0883/23: Dosage claims and their entitlement to priority when only the clinical trial protocol was disclosed in the priority application

In a recently issued decision by the EPO’s Board of Appeal (BoA), the BoA held that claims directed to a combination of active pharmaceutical ingredients (APIs) at particular doses were …

Read article

The end of the Brexit overhang for trade marks: review, refile and revoke.

On the 31st December 2025, five years will have passed since the end of the Brexit transitional period on 31st December 2020. Why is this relevant? For UK cloned trade …

Read article
Event - 14th January 2026

Seminar on The aftermath of G1/24 - has anything changed?

HGF is hosting a The aftermath of G1/24 – has anything changed? Which will be followed by networking, apero, and snacks. The Seminar will be held on Wednesday, 14th January …

Event details

Personal names as 'brands' in the world of fashion

Episode 1 Personal names as ‘brands’ in the world of fashion    

Read article

Colour in fashion and the difficulties of protecting it

Episode 2 Colour in fashion and the difficulties of protecting it  

Read article

Trade marks which are fashion products, and fashion products which are trade marks

Episode 3 Trade marks which are fashion products, and fashion products which are trade marks

Read article

Zombie Fashion Brands

Episode 4 Zombie Fashion Brands  

Read article

Trade mark rights protecting fashion designs

Episode 5 Trade mark rights protecting fashion designs

Read article